Re-sequencing, the identi®cation of the speci®c variants in a sequence of interest compared with a known genomic sequence, is a ubiquitous task in today's biology. Universal arrays, which interrogate all possible oligonucleotides of a certain length in a target sequence, have been suggested for computationally determining a polynucleotide sequence from its oligonucleotide content. We present here new methods that use such arrays for re-sequencing. Our methods are applied to data obtained by the polymerase signaling assay, which arrays single-based primer extension reactions for either universal or partial arrays of pentanucleotides. The computational analysis uses the spectrum alignment algorithm, which is re®ned and enhanced here in order to overcome noise incurred by the use of such short primers. We present accurate resequencing results for both synthetic and ampli®ed DNA molecules.
INTRODUCTION
Genomic sequence is now abundant: the genomes of more than a hundred species including human have already been sequenced. Despite this profusion of data, sequencing is still a routine task in laboratory work. This demand for sequencing is to a large extent targeted at molecules whose nucleic acid sequences are approximately known in advance. This is the case in validation of sequences, in cDNA sequencing, and in detection and typing of polymorphisms or germline/somatic mutations. All these tasks can be categorized as`resequencing' tasks, i.e. the determination of a nucleotide sequence which is known to be a variant of some previously sequenced reference molecule. This promotes re-sequencing as a key endeavor in today's biology (1) .
The identi®cation of millions of human polymorphisms (2) and the ongoing mapping of all common human haplotypes (3, 4) will lead in the near future to a situation where virtually all common sequence variations have been mapped. Nevertheless, due to the more modern expansion of the human race, much of the observed variation is comprised of rare polymorphisms and familial mutations. To determine the correct alleles of a certain locus borne by a speci®c individual it is thus insuf®cient to type only known single nucleotide polymorphisms (SNPs) that are abundant in the population: one would ultimately need to detect sporadic variations as well, and so, for many studies, complete re-sequencing will remain a key task in accurate genetic typing of individuals.
Sequencing by hybridization (SBH) was invented as an alternative to gel-based sequencing (5±7). This method makes use of a universal DNA microarray, which harbors all oligonucleotides of length k (called k-mers or`words') as probes. These oligonucleotides are assayed with an unknown DNA target fragment, whose sequence we would like to determine. Under ideal conditions, this target molecule would hybridize to all words whose Watson±Crick complements occur somewhere along its sequence. Thus, in principle, one could determine in a single microarray reaction the set of all k-long sub-sequences of the target (this set is called the target's spectrum) and try to infer the sequence from these data.
SBH is greatly impeded by ambiguity in target reconstruction. Depending on k and on the target length, there may be severalÐor manyÐalternative sub-sequences, within any tested target, that have the same spectrum and are thus indistinguishable. Hence, spectrum data simply do not contain suf®cient information to uniquely resolve targets of reasonable lengths (8, 9) . Alternative sources of information have been suggested to complement the spectrum data (10±12).
One possible source of complementary information for SBH is the reference sequence. Re-sequencing by hybridization (RSBH) is the task of reconstructing the target sequence using its spectrum and a reference sequence to which the target is similar. We recently developed a computational method, called spectrum alignment, for RSBH (13) . Spectrum alignment uses a probabilistic representation for the reference sequence information and the spectrum signals. It computes the most likely target sequence given these data. Here we shall study the adaptation of spectrum alignment to handle real experimental data, and we validate the theoretical method with actual re-sequencing results.
An alternative strategy for array-based re-sequencing uses straight hybridization to speci®c, partial arrays. This strategy uses the probe array as a massively parallel assay for single nucleotide primer extension genotyping, and seeks a mutation or potential polymorphism at each site along the target. The probes on such an array are a set of k-mers that tile the target sequence and its variants. The advantage of this approach is that it does not require the complete set of k-mers to be used, allowing the use of fewer and longer oligonucleotides with reasonable cost. The disadvantage is that such arrays can only detect the pre-determined sequence variations for which they were designed. Moreover, a new array needs to be created for each new re-sequencing reference. Such arrays have been designed for re-sequencing, among others, the P53 tumor suppressor gene (14, 15) , HIV protease (16) the HLA locus (17) and other genomic regions (18) . See Tillib and Mirzabekov (19) for a review of such methods. The use of SBH in practice raises two con¯icting issues. On the one hand, short oligonucleotide hybridizations are less speci®c and less accurate than longer ones. On the other hand, the number of probes in a universal array grows exponentially with the probe length, so feasible lengths are severely limited. While universal arrays of 9mers have been constructed (20) , for universal arrays to be cost-effective for most applications, they need to be much smaller than these gigantic sets of 4 9 » 2.5 Q 10 5 oligonucleotides. Other formats of arrays have been attempted, using the probes sequentially, rather than on one large array (21) , or pooling subsets of the probes (22) . The natural, generic strategy would be to use shorter probes, which allow the complete set of oligonucleotides to be costeffectively used in each array (23) . The reader is referred to reviews on SBH formats (24, 25) .
Small universal arrays must use very short probes, which worsen the hybridization speci®city problem. In order to create a practical assay for re-sequencing by universal arrays one needs a probing assay which is as speci®c as possible even for 5mers or 6mers (23) , and computational means to overcome the low speci®city and high noise in the assay. In this work, we have used the polymerase signaling assay (PSA), a method for probing a target sequence for the presence of short oligonucleotides using enzymatic discrimination, based on single-nucleotide primer extension, giving better accuracy than hybridization alone (26±28). Even using this method, noise is a major problem. We therefore develop algorithms to increase signal speci®city by computational means, and report the results of applying these algorithms on partial and universal PSA arrays.
MATERIALS AND METHODS

Target molecules
Target samples included 10 synthetic double-stranded DNA molecules of length 25±35 bp and 32 PCR amplicons of length 100±140 bp (see Table 1 ).
PSA
The PSA is an accurate method for parallel re-sequencing examination of polynucleotides up to several thousand base pairs long (26±28). PSA uses a glass slide, onto which probes are spotted in an arrayed fashion. Our plates included 192 spots each, where 16 spots are used as controls, and 176 represent a unique ®ve-base probing sequence, representing 5mers and sequence variations speci®cally related to the target sequence being tested. Used for analysis of AGT exon 2 and CFTR exon 11, these experiments simplify the approach from the true`universal array' of 5mers. A complete universal array, which may be used for analysis of any arbitrary sequence, has a unique ®ve-base probe for each of the 4 5 = 1024 possible pentanucleotide combinations. These larger arrays were constructed by using several sub-arrays. Each probe is a 29mer, comprising a capture motif, which is identical for all probes, and a probe-speci®c oligonucleotide pentamer. The capture motif, U 18 , is separated from the attachment moiety by a spacer amidite (Spacer 18; Glen Research). The capture and probe motifs are separated by a segment of six bases of completely random content (i.e. the amidite source for these synthesis steps is made of a mixture of 25% each of A, C, G and T), such that this segment is a structural spacer, and should not play any role in the resequencing event. The probe-speci®c nucleotide combinations are designed to perfectly match every possible 5mer segment along a target.
Target molecules are PCR amplicons, one short (ideally 100±150 bases) amplicon for each of the target sequence, with an attached poly(A) tail, appended to the 5¢ end of one of the PCR primers. Any reasonable set of PCR primers is acceptable, so long as the short amplicon can be achieved in good yield. After PCR, the double-stranded amplicons are degraded to a single strand, using a combination of a phosphorothioated PCR primer and an exonuclease, as described previously (14) . When applied to the slide at 37°C, these tails bond to the poly(U) segment of the capture probe, and the entire target molecule is thus always in the vicinity of the speci®c probe. Whenever the target sequence contains a sequence that perfectly matches the speci®c probe, the complementary sequences can form a transient duplex. PSA also incorporates DNA polymerase and¯uorescently labeled terminating nucleotide triphosphates, which allow single-base extension of the speci®c probes that have been matched. The presence of the enzyme stabilized the transient duplexes within a primed tertiary complex, and thus stabilization and primer extension occur as a linked biochemical process. The¯uorescent slide is then scanned to detect the spots that signal a match between their probes and the target sequence. Exact details of this assay are described elsewhere (26±28).
Computational analysis: enhancements to spectrum alignment
Computational analysis is based on the spectrum alignment algorithm (13) . We outline this method in brief and then describe the improvements made in this study in order to transform spectrum alignment into a useful, practical method, which could handle the real PSA signals.
The input to spectrum analysis comprises of a reference sequence in the form of a hidden Markov model (HMM) for a polynucleotide sequence, as well as the results of the array experiment. HMMs are a powerful method for describing sequence pro®les and variations (29) . Intuitively, it can be thought of as a sequence of states that describe match/ mismatch, insertion, or deletion in the target with respect to the genomic reference sequence. The HMM registers probabilities for transition between those states, as well as probabilities of producing each nucleotide at each state. Results of the arrayed probing reactions are formulated as a probabilistic spectrum, i.e. a pair P 1 (x) and P 2 (x) for each k-mer x, where: P 1 (x) = Prob(observed signal for probe x | x matches the target) and P 0 (x) = Prob(observed signal for probe x | x does not match the target)
Evaluation of P 1 (x) and P 0 (x) from x's¯uorescence signals is discussed below. For probes y that are absent from the array, P 1 (y) and P 0 (y) are set to re¯ect occurrence probability of y along putative targets that are randomized variants of the reference sequence.
The enhanced algorithm applies spectrum alignment iteratively. Each iteration re-evaluates the putative target sequence of a speci®c region along this sequence, assuming correctness of the rest of the reconstructed sequence. Putative incorrect regions are identi®ed by their lower likelihood. This is done in order to correctly interpret probe signals which are positives, but are due to a match that occurred outside the focus region. For re-sequencing a speci®c, focus region we need to ®nd the most likely chain of HMM states which starts and terminates with the oligonucleotides that match the ends of that region. This is computed by a dynamic program (30). Per-probe training P 1 (x) is evaluated as follows. When we have suf®cient examples of¯uorescent signals for the probe x with known positive match to some known target, we can evaluate the mean signal m 1 (x) for the matched probe, and its standard deviation s 1 (x). A goodness-of-®t test does not reject the hypothesis that samples are normally distributed (data not shown). P 1 (x) is then set to the P-value for signal s(x) to be drawn from a normal distribution with mean m 1 (x) and standard deviation s 1 (x). Evaluation of P 0 (x) is done similarly.
(In practice, we assume s(x) = s 1 (x) = s 0 (x) and evaluate s(x) based on the two sets of samples.) When we do not have suf®ciently many samples of positive/ negative matches to the probe x, we enrich the occurrence count of positive/negative matches to the probe x by adding to it the count of another probe y, whose signals are similarly distributed, but whose counts are not sparse. For each candidate probe y we use its computed normal distributions, N[m 1 (y), s 2 (y)] and N[m 0 (y), s 2 (y)], to evaluate the likelihood of the observed (matched and unmatched, respectively) signals for x. The probe y = y* that maximizes this likelihood is chosen and its counts are added to those of x. The combined count is used to evaluate expectancies m 1 , m 0 and standard deviation s for x that together de®ne the normal distributions of its matched/unmatched signals.
Probe-independent training
For learning the distribution in an unsupervised manner we employ an alternative strategy, which does not build on experience with previous assays, and does not ®t the distribution for each probe. Instead, we utilize the distributions of signals with positively and negatively matched probes in the current data set.
Obviously, we do not know in advance for the current data set whether a probe is perfectly matched by the target or not, as the target is yet unknown. However, we can evaluate the probability of that event with respect to a random target that is similar to the reference sequence as much as the true target is assumed to be. Such random targets can be drawn using the HMM, which models the probabilistic space of such sequences. We thus generate N = 100 candidate targets, and average the matched/unmatched status of the probe x as follows. We empirically estimate the probability of a perfect match, based on all randomized targets, as the fraction of probes attaining a certain signal among perfectly matched probes:
tY sx random target t N`tY I P 0 (x) is analogously estimated.
RESULTS
The ultimate goal of this research is to establish the practicality of universal arrays for re-sequencing. The question that we address is whether one can make complete yet reasonably small arrays of probes, by limiting probe length, to accurately re-sequence DNA sequences of practical length. We thus performed a series of blind tests, in which the target sequence was unknown. One set of assays comprised of simple genotyping tests, where the target sequence was either the wild type or a single-nucleotide mutant thereof. Other assays were re-sequencing tests, wherein the target could have been any variant of the known reference sequence. We ®rst constructed partial, tiling arrays. Some of these arrays consisted of probes that tile variants of exon 2 of angiotensinogen, while others tile exon 11 of CFTR. We then constructed and tested complete, universal arrays. We used arrays of 5mer probes, for which only 1024 different oligonucleotides are needed (see Table 2 for the list of arrays used). Various target molecules were re-sequenced (Table 1) . To obtain as much speci®city as possible from these short probes, we applied the PSA protocol (see Materials and Methods). The image, a confocal¯uorescence scan, of one such universal array is presented in Figure 1 .
Arrayed PSA reactions produce data sets of raw¯uorescent signals. When reconstructing a target sequence using spectrum alignment, the quantity of interest for each probe is the likelihood of a perfect match. More precisely, given the raw signal s(x) for a probe x, one needs to compute the probabilities P 1 (x) = Prob[s(x) | x is perfectly matched by the target] and P 0 (x) = Prob[s(x) | x is not perfectly matched by the target]. Although PSA provides cleaner signals than hybridization, signals are still very noisy. The observed noise might be due either to stochastic effects, causing variation in replicate observations of the same intensity, or to hidden variables that distinguish between signals. As seen below, both factors contribute to the signal distribution, and we can exploit our knowledge of some hidden variables, such as individual probe differences, to improve signal analysis. Overall distributions of signals are presented in Figure 2 . Figure 2 , for most of the signal range, the matched and unmatched probabilities are of the same order of magnitude. Thus, the log-likelihood term log[P 1 (x)/P 0 (x)] contributed by most probes is approximately zero, rendering the model statistically weak. The weak separation of the P 0 and P 1 distributions can have two causes: either the individual per-probe distributions are separated weakly for most probes, or they are separated, and their superposition causes the weak separation. Fortunately, as exempli®ed by Figure 3 , the latter case is in effect. For example, T-rich probes produce very high signals, due to the poly(A) capture probes used in PSA (see Materials and Methods). Therefore, negative signals for such probes would be deemed positive according to the overall signal distribution, which is a mixture of many different per-probe distributions (see Fig. 2 ). This suggests empirically estimating P 0 and P 1 on a per-probe basis. For each probe x, for each signal level s, we estimate the probability of observing a signal s(x) under the assumption of a perfect match in the target sequence. We assume such signals are normally distributed, with a probe-speci®c mean and variance, providing the distribution of P 1 (x). The distribution of P 0 (x) is analogously estimated.
We study and test two scenarios. First, we present a method to estimate P 0 and P 1 from a single array only. Each of these two distributions is assumed to be the same for all probes, for lack of better information. We call this method probeindependent training. Secondly, in cases in which we have several arrays that were assayed using the same protocol, but with different target molecules, better analysis is possible: we estimate individual signal distributions for each probe under the approximate assumption that these arrays are replicates of the same experiment. We call this method per-probe training.
In probe-independent training, in the absence of any prior information on the signal distributions, we use the following approximation: we generate in simulations many random targets, which are variants of the reference sequence, and collect statistics on the signal distributions of matched and unmatched probes. In this manner, we attempt to model the statistical properties of the actual target sequence used in the assay, without having any further information about the actual biochemical outcome of known target variants (see Materials and Methods).
In per-probe training, one has several arrays that were assayed using a similar reference, but with different mutations. This is the case, for example, for each individual data set in Table 2 , which used several arrays. This is also the case for all the data sets of the CFTR arrays that together constitute a much richer set. Thus, a number of experiments with extensive perfect match data are available. In order to resolve the target in a speci®c array, we train each probe using all other arrays with match/mismatch for the current probe. We pool the matched/unmatched signal levels for each probe from all arrays and obtain a richer distribution. When that distribution is not based on suf®ciently many probe occurrences, we enrich that distribution by that of another, similar probe (see Materials and Methods). As samples accumulate, richer and richer training sets can be built and exploited this way, and the statistical con®dence of any single experiment will increase.
The two training methods present a trade-off. Probeindependent training uses a rich, yet coarse, set of observations, and forms a distribution that may be not representative of the speci®c probe. The per-probe method uses a ®ner set of observations, which may be too small a sample, and thus over®t the estimated distribution. We also consider a similar trade-off with respect to the experiments used to learn the perprobe distribution. We compare results of analysis based on learning this distribution from the current data set only, with learning based on all data sets, or on all other data sets except the current one. Figure 4 presents a comparison of the results obtained by each of the training methods. Per-probe analysis based on all other arrays is superior to probe-independent analysis based on the current data set only. In per-probe methods, there is a trade-off between training which is based only on the same data set and training on all data sets: the more re®ned, but sparser training per data set makes more false calls at known SNP sites, but reports less spurious false positives due to over®tting. The estimated probabilities serve as input to the spectrum alignment computational engine. Table 3 presents results for blind tests of genotyping and for re-sequencing tests. For angiotensinogen exon 2, targets were either wild type or mutated for a speci®c polymorphism. The algorithm was not calibrated beforehand with any prior information regarding the identity of this polymorphic site, i.e. the reference sequence model was considered to have an equal likelihood to contain a mutation at any point along the target sequence. The genotype call on this site was correct for six out of six samples, and no spurious calls were made (although permitted by the algorithm). Analysis for arrays in this data set was carried out using probe-independent training. Although each of the 5mer probes may not necessarily give an entirely speci®c assay signal, their joint analysis using the spectrum alignment algorithm (13) utilizes all the statistical information available to produce a strong, combined signal. Figure 5 presents results for the CFTR exon 11. For resequencing this target (with either partial or universal arrays), we used as reference not only the genomic sequence, but also known mutations from the Human Genome Mutation Database (www.hgmd.org). Altogether, in 30 arrays, we resequenced 2.6 kb of DNA. Out of 64 known polymorphisms, 60.5 were correctly typed (see Fig. 4 for details on the counting procedure), and two additional spurious mutations were falsely detected. This true-positive rate of 95% is to be contrasted with the 30% error rate introduced by pentamer biochemistry (Fig. 2) . Observe that this analysis was carried out without any attempt to detect heterozygocity. While genotyping does require the detection of heterozygotes (see Discussion), we employed a ®rst, simple approach to test the feasibility of our methodology, which ignored heterozygocity, and therefore technically counted heterozygotes as errors. Out of the 56 homozygotes, we had only one error.
A non-coding region on chromosome 18 was also resequenced by universal arrays (data set 6, arrays 1±4). For this target sequence we had no prior knowledge of the mutant sites. For this segment we missed one of the mutations in four resequenced targets of total length of 300 bp. Both CFTR targets assayed with universal arrays (data set 6, arrays 5 and 6) were successfully re-sequenced.
Although we account for per-probe signal effects by perprobe training, the major source of remaining error appears to be systematic bias, rather than stochastic effects between replicates: most of the failed genotypes involve the GGT551G[G/A]T mutation. Thus, apparently, averaging many experiments will not be helpful in eliminating such errors, but further understanding and modeling of the causes of such systematic bias may solve the problem.
The spectrum alignment algorithm was implemented on both Windows and Unix platforms. The implementation incorporates a re®ned analysis of heterozygote samples, although the results presented were analyzed without this feature. The heterozygotes analysis would obviously need to be added for full functionality. In addition, we implemented a visualization tool, called SNP-o-gram, for presentation of resequencing results. This Windows application displays the reference and re-sequenced target, along with plots that indicate the likelihood of each base call, similar to standard traces of gel-based sequencing machines. Figure 6 displays the SNP-o-gram of two re-sequenced targets.
DISCUSSION
Re-sequencing genomic information is a major task in today's biology, providing essential data for various research and diagnostics applications. The term`re-sequencing' implies that one has signi®cant information on the reference, thus determination of the target sequence should avoid complete sequence determination de novo. A promising strategy for resequencing is the use of arrayed short probes. An array containing all possible probe sequences of a particular length can serve as a universal assay for all possible target sequences. In order to be economical, one should minimize probe number, and therefore probe length. However, shorter probes can reduce the accuracy of the assay, so robust assay conditions and analytical processes need to be developed in concert with this simpli®ed array approach.
This study shows the practicality of re-sequencing by an array of probes and detection by polymerase-mediated singlebase extension. A combination of the polymerase, which imparts a much higher speci®city than DNA hybridization alone, and enhanced computational methods of the resulting data from the DNA array assay, make it possible to handle noisy signal incurred by the use of short probes. Our method is suf®ciently versatile to handle different sequences, yet utilize the information from the reference sequence. The analytical method is applied here to actual assay data for the ®rst time.
We report successful re-sequencing of 100 bp fragments using pentanucleotide probes. This suits several key applica- tions for re-sequencing, in which the sequence of a target exon, for example, may differ from its reference at many polymorphic or mutable sites. Such applications include genetic, diagnostic tests for highly polymorphic genes like CFTR that has over a thousand known mutations, many of them treatable upon proper diagnosis. An additional application involves detecting somatic mutations in onco-related genes. Accurate typing of pathogens can be also be achieved, by re-sequencing genes that are common to all candidate pathogens (e.g. 16S RNA).
This work uses mere 5mer probes, and achieves 100 bp of sequence. Practical prospects for universal arrays in largescale re-sequencing probably depend on the ability to sequence fragments longer by an order of magnitude. One possibility would be to scale the probe length to include all8mers, or even all-9mers, arrays that are feasible with some current industrial technologies. Indeed, our simulation studies (13) indicate that the feasible target length for re-sequencing approximately doubles when increasing by one the probe length in a universal array, even without taking into account the potential increase in accuracy due to longer probes. This increased accuracy is expected to enable improvement of the overall ®delity of the re-sequencing process. Figure 5 . Summary of re-sequencing results for CFTR. The wild-type reference sequence is displayed along with call-outs for statistics on the typing of sites with potential mutations found at speci®c nucleotides. In total, 60.5 out of 64 mutations were correctly typed in common SNP sites (white callouts). Two mutations were called in spurious sites (gray call-outs). In these early studies, it was important for the biochemical process to maximize signal intensity over background. The potential use of longer probes could also go together with more stringent hybridization/extension conditions that would have the potential of reducing spurious biochemical outcomes. Newer, more intense and more sensitive detection molecules and scanning technologies would help access these likely weaker signals, and could push sensitivity well beyond the simple method of incorporation of singly labeled¯uorescent nucleotides. Any of these alternatives could be used to increase accuracy, and would enable improvement of the overall ®delity of the re-sequencing process.
A different alternative is to use the 5mer re-sequencing technique to explore the small number of differences that might be the more likely goal in some re-sequencing studies. In this case, detection of small variations with respect to the reference sequence becomes far more important.
The important issue of detecting heterozygotes in this same manner was not addressed in this study. It is possible to achieve these goals within the spectrum alignment framework, in the following manner. In theory, one needs to ®nd a pair of sequences, corresponding to a pair of paths in the spectrum alignment graph, that maximize the likelihood of the signals under the assumption of the two corresponding haplotypes. This likelihood is an expression which sums up individual edge contributions, very similarly to the standard homozygous score. In practice, the two haplotypes are expected to be quite similar to each other. Therefore, the two corresponding paths are intertwined, and often overlap in many edges. The resolution of one haplotype can be performed as in the homozygous case. We propose to continue and resolve regions where the two paths are distinct in a segment by segment fashion. When examining such a segment, one can look for potential heterozygocity by using the distilled spectrum machinery to ®lter out the spectrum of the ®rst haplotype (13) . As the current data set focuses on homozygote targets (37 out of 42), we could not adequately test this approach in this study, and this will be done in a future study.
The computational developments presented here are driven by the nature of errors incurred by the biochemical assay. Nevertheless, these methods are general, and apply also to data obtained by other kinds of assays. In particular, as probing technology improves in quality, cost and throughput, re-sequencing of longer DNA segments is expected to be practical soon. Computational methods such as the ones presented in this work may provide the means to handle such assays in the future.
